An expected delay in a key step in CK Hutchison's planned sale of its Panama ports to a U.S. group, a deal blasted by Chinese ...

Announced the acceptance of the New Drug Application (NDA) by the U.S. Food and Drug Administration (FDA) for OLC for the treatment of hyperphosphatemia in patients with CKD on dialysis. The FDA set a ...

MZE829 Phase 2 HORIZON Trial Enrolling Patients with APOL1 Kidney Disease (AKD); Initial Data Expected in Q1 2026MZE782 Phase 1 Healthy Volunteer ...

A New Brunswick woman wants to donate one of her kidneys to her cousin in Ontario but discovered not having a family doctor ...

Hua Medicine Announces 2024 Annual Results - HuaTangNing completed its first full year for reimbursement under the National Rei ...

A “Strong Buy” rating from Wall Street indicates that analysts believe a stock has the potential for future price ...

Cinnamon tea is a source of antioxidants and may bring various health benefits. Learn how to make it and possible side ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

SeaStar Medical Fourth Quarter and Year-End 2024 Financial Results Conference Call Thursday, March 27, at 4:30 p.m. ET / 1:30 p.m. PT The live webcast and replay can be found here. The webcast replay ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

Travere Therapeutics, Inc., today announced that the Company will present three abstracts, including one late-breaking oral presentation, at the upcoming National Kidney Foundation (NKF) Spring ...

Deficiency of the pancreatic progenitor cell differentiation and proliferation factor gene was identified as a risk factor ...